Skip to content

CapEx at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$347M+33.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$230.6M+0.6%
Gilead Sciences logo
Gilead SciencesGILD
$117M+12.5%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$23K-73.3%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$769K+0.4%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$62K

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's capex?
Precigen (PGEN) reported capex of $258K in Q1 2026.
How has Precigen's capex changed year-over-year?
Precigen's capex decreased by 58.5% year-over-year, from $622K to $258K.
What is the long-term trend for Precigen's capex?
Over 4 years (2021 to 2025), Precigen's capex has grown at a -27.6% compound annual growth rate (CAGR), from $7.25M to $2M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.